Moderna Management
Management criteria checks 4/4
Moderna's CEO is Stephane Bancel, appointed in Oct 2011, has a tenure of 12.5 years. total yearly compensation is $17.07M, comprised of 9.2% salary and 90.8% bonuses, including company stock and options. directly owns 5.5% of the company’s shares, worth $2.20B. The average tenure of the management team and the board of directors is 4 years and 9.9 years respectively.
Key information
Stephane Bancel
Chief executive officer
US$17.1m
Total compensation
| CEO salary percentage | 9.2% |
| CEO tenure | 12.5yrs |
| CEO ownership | 5.5% |
| Management average tenure | 4yrs |
| Board average tenure | 9.9yrs |
Recent management updates
Recent updates
Moderna, Inc.'s (NASDAQ:MRNA) Prospects Need A Boost To Lift Shares
Apr 22
Moderna: Considering The Cancer Vaccine Angle
Apr 11Moderna Continues To Build A Pipeline
Apr 03Lukewarm Reaction To Moderna's Vaccine Day Sums Up Fine Margins In Play
Mar 27Moderna, Inc. (NASDAQ:MRNA) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
Feb 27Moderna: Counting On Pipeline Too Much
Feb 23Moderna: Highly Uncertain Future For mRNA Vaccine In A Post-Pandemic World
Feb 16Moderna: Fade 2025 Outlook
Jan 15Moderna, Inc. (NASDAQ:MRNA) Held Back By Insufficient Growth Even After Shares Climb 26%
Dec 29Need To Know: The Consensus Just Cut Its Moderna, Inc. (NASDAQ:MRNA) Estimates For 2024
Nov 03Moderna, Inc. (NASDAQ:MRNA) Shares Could Be 30% Below Their Intrinsic Value Estimate
Oct 18Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 47% Discount?
May 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$17m | US$2m | -US$5b |
| Sep 30 2023 | n/a | n/a | -US$3b |
| Jun 30 2023 | n/a | n/a | US$1b |
| Mar 31 2023 | n/a | n/a | US$5b |
| Dec 31 2022 | US$19m | US$1m | US$8b |
| Sep 30 2022 | n/a | n/a | US$12b |
| Jun 30 2022 | n/a | n/a | US$14b |
| Mar 31 2022 | n/a | n/a | US$15b |
| Dec 31 2021 | US$18m | US$990k | US$12b |
| Sep 30 2021 | n/a | n/a | US$7b |
| Jun 30 2021 | n/a | n/a | US$3b |
| Mar 31 2021 | n/a | n/a | US$598m |
| Dec 31 2020 | US$13m | US$946k | -US$747m |
| Sep 30 2020 | n/a | n/a | -US$597m |
| Jun 30 2020 | n/a | n/a | -US$488m |
| Mar 31 2020 | n/a | n/a | -US$505m |
| Dec 31 2019 | US$9m | US$921k | -US$514m |
| Sep 30 2019 | n/a | n/a | -US$535m |
| Jun 30 2019 | n/a | n/a | -US$499m |
| Mar 31 2019 | n/a | n/a | -US$459m |
| Dec 31 2018 | US$59m | US$863k | -US$402m |
| Sep 30 2018 | n/a | n/a | -US$299m |
| Jun 30 2018 | n/a | n/a | -US$280m |
| Mar 31 2018 | n/a | n/a | -US$266m |
| Dec 31 2017 | US$7m | US$651k | -US$270m |
Compensation vs Market: Stephane's total compensation ($USD17.07M) is about average for companies of similar size in the US market ($USD13.51M).
Compensation vs Earnings: Stephane's compensation has been consistent with company performance over the past year.
CEO
Stephane Bancel (50 yo)
12.5yrs
Tenure
US$17,068,514
Compensation
Mr. Stephane Bancel serves as Board Director of Indigo Agriculture Inc since 2020. Mr Bancel serves as Interim President of Valera LLC. Mr. Bancel serves as a Special Partner at Flagship Pioneering since F...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 12.5yrs | US$17.07m | 5.5% $ 2.2b | |
| President | no data | US$7.34m | 0.43% $ 171.6m | |
| Chief Financial Officer | 1.6yrs | US$4.32m | 0.0013% $ 527.9k | |
| Chief Legal Officer & Corporate Secretary | 2.8yrs | US$4.31m | 0.0024% $ 967.9k | |
| Chief Technical Operations & Quality Officer | 1.3yrs | no data | no data | |
| Chief Information Officer | 1.3yrs | no data | no data | |
| Senior VP & Head of Investor Relations | 5yrs | no data | no data | |
| Senior Director of Corporate Communications | no data | no data | no data | |
| Chief Human Resources Officer | 4.5yrs | no data | no data | |
| Chief Development Officer | 4.3yrs | no data | no data | |
| Chief Data & AI Officer | no data | no data | no data | |
| Senior VP & Head of Global Regulatory Science | 4yrs | no data | no data |
4.0yrs
Average Tenure
49yo
Average Age
Experienced Management: MRNA's management team is considered experienced (4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 13.1yrs | US$17.07m | 5.5% $ 2.2b | |
| Co-Founder | 14.3yrs | US$663.52k | 0.54% $ 214.9m | |
| Independent Director | 3.8yrs | US$478.55k | 0.00018% $ 72.0k | |
| Independent Non Executive Director & Member of Scientific Advisory Board | 13.3yrs | US$452.92k | 3.01% $ 1.2b | |
| Member of Technology Advisory Board | 9.9yrs | no data | no data | |
| Independent Director | 3.1yrs | US$476.25k | 0.00036% $ 144.0k | |
| Member of Technology Advisory Board | 9.9yrs | no data | no data | |
| Independent Non Executive Director | 4.3yrs | US$467.30k | 0.0054% $ 2.2m | |
| Member of Technology Advisory Board | 9.9yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Chairman of Scientific Advisory Board | 9.9yrs | no data | no data | |
| Member of Technology Advisory Board | 9.9yrs | no data | no data |
9.9yrs
Average Tenure
64yo
Average Age
Experienced Board: MRNA's board of directors are considered experienced (9.9 years average tenure).